Recombinant human growth factor-Fc fusion protein (Yifan Pharmaceutical)

重组人生长激素-Fc融合蛋白（亿帆）

Report date: 2022/10/20 13:48:45

Base Information

Drug NameRecombinant human growth factor-Fc fusion protein (Yifan Pharmaceutical)
Drug Alias NameF-899
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYifan Pharmaceutical Research Institute (Beijing) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesYifan Pharmaceutical Research Institute (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A